IMMU : Summary for Immunomedics, Inc. - Yahoo Finance

U.S. Markets open in 7 hrs 34 mins

Immunomedics, Inc. (IMMU)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.04+0.11 (+2.80%)
At close: 4:00PM EST
People also watch
IMGNARRYXOMAPGNXAGEN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.93
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range3.88 - 4.24
52 Week Range1.61 - 5.44
Volume3,366,874
Avg. Volume1,724,504
Market Cap428.01M
Beta2.66
PE Ratio (TTM)-6.48
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 24/7 Wall St.4 days ago

    Thursday’s Biggest Biopharma Winners

    The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. At first 2017 seemed like it could be different for this sector, ...

  • GlobeNewswire5 days ago

    Immunomedics to Mail Letter to Stockholders Highlighting Unprecedented Progress Toward Enhanced Value Creation

    Urges Stockholders to Vote“ FOR” Each of Immunomedics’ Highly-Qualified Director Nominees on the WHITE Proxy Card. venBio Rejects Constructive, Stockholder-Friendly Settlement Proposal and Insists on Unilateral ...

  • Business Wire6 days ago

    venBio Sends Letter to Immunomedics Stockholders

    venBio Select Advisor LLC , the beneficial owner of approximately 9.5 million shares, or 9.0%, of Immunomedics, Inc. and its largest stockholder, today sent a letter to Immunomedics stockholders in connection with venBio’s nomination of four highly-qualified candidates – Scott Canute, Peter Barton Hutt, Dr.